Skip to content

BIONOVATE TECHNOLOGIES CORP.: 10-Q filed 2015-02-11

What BIONOVATE TECHNOLOGIES CORP. reported in its quarterly report filed 2015-02-11 (fiscal Q2 2015): 17 published measures, 70 facts as tagged in accession 0001062993-15-000610.

This filing

Form
10-Q (quarterly report)
Filed
2015-02-11
Fiscal period
fiscal Q2 2015
Accession
0001062993-15-000610 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONOVATE TECHNOLOGIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-312,256USD
At 2014-06-30967USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-3198,436USD
At 2014-06-3083,882USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31-96,180USD
At 2014-06-30-82,915USD
At 2013-06-308,647USD
At 2012-06-30-14,474USD
At 2011-06-30-18,273USD
At 2010-07-18104USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-312,256USD
At 2014-06-30967USD
At 2013-12-317,137USD
At 2013-06-3057,677USD
At 2010-07-180USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-10,213USD92
2014-07-01 to 2014-12-31-20,735USD184
2010-07-19 to 2014-12-31-214,303USD1627
2013-07-01 to 2014-06-30-91,205USD365
2013-10-01 to 2013-12-31-25,415USD92
2013-07-01 to 2013-12-31-40,641USD184
2012-07-01 to 2013-06-30-87,533USD365
2011-07-01 to 2012-06-302,863USD366
2010-07-19 to 2011-06-30-17,693USD347

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-07-01 to 2014-12-31-6,181USD184
2010-07-19 to 2014-12-31-115,867USD1627
2013-07-01 to 2013-12-31-50,965USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-10-01 to 2014-12-31944USD92
2014-07-01 to 2014-12-312,959USD184
2010-07-19 to 2014-12-3197,808USD1627
2013-10-01 to 2013-12-311,024USD92
2013-07-01 to 2013-12-313,773USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-07-01 to 2014-12-310USD184
2010-07-19 to 2014-12-31113,806USD1627
2013-07-01 to 2013-12-310USD184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-10-01 to 2014-12-310USD92
2014-07-01 to 2014-12-310USD184
2010-07-19 to 2014-12-311,335USD1627
2013-10-01 to 2013-12-310USD92
2013-07-01 to 2013-12-310USD184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-10-01 to 2014-12-3110,205USD92
2014-07-01 to 2014-12-3121,110USD184
2010-07-19 to 2014-12-31235,310USD1627
2013-10-01 to 2013-12-3126,439USD92
2013-07-01 to 2013-12-3143,275USD184

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-8USD92
2014-07-01 to 2014-12-31375USD184
2010-07-19 to 2014-12-3122,342USD1627
2013-10-01 to 2013-12-311,024USD92
2013-07-01 to 2013-12-312,634USD184

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-31112,195USD
At 2014-06-30112,195USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-314,317USD
At 2014-06-30-3,153USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-6,982USD92
2014-07-01 to 2014-12-31-13,265USD184
2010-07-19 to 2014-12-31-209,986USD1627
2013-10-01 to 2013-12-31-24,985USD92
2013-07-01 to 2013-12-31-40,216USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-317,573USD92
2014-07-01 to 2014-12-3115,686USD184
2010-07-19 to 2014-12-31107,726USD1627
2013-10-01 to 2013-12-3112,874USD92
2013-07-01 to 2013-12-3125,935USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-07-01 to 2014-12-310USD184
2010-07-19 to 2014-12-31113,806USD1627
2013-07-01 to 2013-12-310USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-12-310USD184
2010-07-19 to 2014-12-310USD1627
2013-07-01 to 2013-12-31-98USD184

Inspect the source

Entity
BIONOVATE TECHNOLOGIES CORP. / CIK 0001575420
Captured
SEC response SHA-256
3a7f453b16552a566daef46e9f3eab08e75589223c6b3f8546d05522bd03527a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575420.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))